Orrick advised CIIG Capital Partners II on the deal, while Latham & Watkins represented Zapp in the transaction. CIIG Capital Partners II, a U.S. publicly listed...
CIIG Capital Partners II’s Merger with Zapp
AgroFresh’s Go-Private Deal
Morrison Foerster advised AgroFresh Solutions Inc. on the deal. AgroFresh Solutions Inc. (“AgroFresh”) (NASDAQ: AGFS), a Philadelphia-based provider of technologies and services to extend the shelf...
FogPharma’s $178 Million Series D Financing
Goodwin Procter advised FogPharma® on the deal. FogPharma® announced its $178 Million Series D financing. FogPharma is a biopharmaceutical company pioneering a new class of precision...
Omni’s $17.5 Million Series A Financing
Goodwin Procter advised Redpoint Ventures on the deal. Redpoint Ventures led Omni’s $17.5 million Series A financing. Redpoint invests in startups across the seed, early and...
MotherDuck’s $12.5 Million Seed Funding Round
Goodwin Procter advised Redpoint Ventures and Madrona Venture Group on the deal. Redpoint Ventures and Madrona Venture Group led the MotherDuck’s $12.5 million seed funding round. Redpoint...
Galenica’s Acquisition of Bahnhof Apotheke Langnau
Niederer Kraft Frey advised the shareholders of Bahnhof Apotheke Langnau AG on the deal. The shareholders of Bahnhof Apotheke Langnau AG sold 100 per cent of the...
Bedford Consulting’s Acquisition of Bluesprint
MAQS Advokatbyrå advised Bluesprint on the deal. Wigge & Partners has advised Keensight Capital and Bedford Consulting. British Bedford Consulting has acquired Bluesprint, the largest independent...
Skanska’s € 500 Million Sustainability Linked Revolving Credit Facility
TM & Partners has advised Skanska on the deal. Skanska entered into a new EUR 500,000,000 multicurrency revolving credit facility linked to its sustainability goals. The...
HydraSpecma’s SEK 835 Million Acquisition of Ymer Renewables AB
Wistrand, in cooperation with lead counsel Kromann Reumert, advised the Danish industrial conglomerate Schouw & Co. and its subsidiary HydraSpecma A/S. HydraSpecma has agreed to acquire...